Multidrug Resistance Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Condition: Tuberculosis, Multidrug-Resistant Intervention: Diagnostic Test: Targeted sequencing using the GenoScreen Deeplex assay Sponsors: University of Cape Town; University of Stellenbosch; Ospedale San Raffaele; Stichting Katholieke Universiteit; University of Cape Town Lung Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Linezolid Dosing Strategies in Drug-Resistant TB
Conditions: Tuberculosis, Multidrug-Resistant; Tuberculosis; Tuberculosis, Pulmonary Interventions: Drug: Linezolid 600 mg; Drug: Linezolid 1200 mg (QD); Drug: Linezolid 1200 mg (TIW); Drug: Bedaquiline 200 mg; Drug: Bedaquiline 100 mg; Drug: Delamanid 300 mg; Drug: Clofazimine 300 mg; Drug: Clofazimine 100 mg Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Condition: Tuberculosis, Multidrug-Resistant Intervention: Diagnostic Test: Targeted sequencing using the GenoScreen Deeplex assay Sponsors: University of Cape Town; University of Stellenbosch; Ospedale San Raffaele; Stichting Katholieke Universiteit; University of Cape Town Lung Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Linezolid Dosing Strategies in Drug-Resistant TB
Conditions: Tuberculosis, Multidrug-Resistant; Tuberculosis; Tuberculosis, Pulmonary Interventions: Drug: Linezolid 600 mg; Drug: Linezolid 1200 mg (QD); Drug: Linezolid 1200 mg (TIW); Drug: Bedaquiline 200 mg; Drug: Bedaquiline 100 mg; Drug: Delamanid 300 mg; Drug: Clofazimine 300 mg; Drug: Clofazimine 100 mg Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Condition: Tuberculosis, Multidrug-Resistant Intervention: Diagnostic Test: Targeted sequencing using the GenoScreen Deeplex assay Sponsors: University of Cape Town; University of Stellenbosch; Ospedale San Raffaele; Stichting Katholieke Universiteit; University of Cape Town Lung Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Linezolid Dosing Strategies in Drug-Resistant TB
Conditions: Tuberculosis, Multidrug-Resistant; Tuberculosis; Tuberculosis, Pulmonary Interventions: Drug: Linezolid 600 mg; Drug: Linezolid 1200 mg (QD); Drug: Linezolid 1200 mg (TIW); Drug: Bedaquiline 200 mg; Drug: Bedaquiline 100 mg; Drug: Delamanid 300 mg; Drug: Clofazimine 300 mg; Drug: Clofazimine 100 mg Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Condition: Tuberculosis, Multidrug-Resistant Intervention: Diagnostic Test: Targeted sequencing using the GenoScreen Deeplex assay Sponsors: University of Cape Town; University of Stellenbosch; Ospedale San Raffaele; Stichting Katholieke Universiteit; University of Cape Town Lung Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Linezolid Dosing Strategies in Drug-Resistant TB
Conditions: Tuberculosis, Multidrug-Resistant; Tuberculosis; Tuberculosis, Pulmonary Interventions: Drug: Linezolid 600 mg; Drug: Linezolid 1200 mg (QD); Drug: Linezolid 1200 mg (TIW); Drug: Bedaquiline 200 mg; Drug: Bedaquiline 100 mg; Drug: Delamanid 300 mg; Drug: Clofazimine 300 mg; Drug: Clofazimine 100 mg Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Condition: Tuberculosis, Multidrug-Resistant Intervention: Diagnostic Test: Targeted sequencing using the GenoScreen Deeplex assay Sponsors: University of Cape Town; University of Stellenbosch; Ospedale San Raffaele; Stichting Katholieke Universiteit; University of Cape Town Lung Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Linezolid Dosing Strategies in Drug-Resistant TB
Conditions: Tuberculosis, Multidrug-Resistant; Tuberculosis; Tuberculosis, Pulmonary Interventions: Drug: Linezolid 600 mg; Drug: Linezolid 1200 mg (QD); Drug: Linezolid 1200 mg (TIW); Drug: Bedaquiline 200 mg; Drug: Bedaquiline 100 mg; Drug: Delamanid 300 mg; Drug: Clofazimine 300 mg; Drug: Clofazimine 100 mg Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Condition: Tuberculosis, Multidrug-Resistant Intervention: Diagnostic Test: Targeted sequencing using the GenoScreen Deeplex assay Sponsors: University of Cape Town; University of Stellenbosch; Ospedale San Raffaele; Stichting Katholieke Universiteit; University of Cape Town Lung Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Linezolid Dosing Strategies in Drug-Resistant TB
Conditions: Tuberculosis, Multidrug-Resistant; Tuberculosis; Tuberculosis, Pulmonary Interventions: Drug: Linezolid 600 mg; Drug: Linezolid 1200 mg (QD); Drug: Linezolid 1200 mg (TIW); Drug: Bedaquiline 200 mg; Drug: Bedaquiline 100 mg; Drug: Delamanid 300 mg; Drug: Clofazimine 300 mg; Drug: Clofazimine 100 mg Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
Condition: Tuberculosis, Multidrug-Resistant Intervention: Diagnostic Test: Targeted sequencing using the GenoScreen Deeplex assay Sponsors: University of Cape Town; University of Stellenbosch; Ospedale San Raffaele; Stichting Katholieke Universiteit; University of Cape Town Lung Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials
The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms
Conditions: Multidrug-resistant Organisms; Ventilator Circuits Intervention: Device: Silver Knight Sponsor: Fu Jen Catholic University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2021 Category: Research Source Type: clinical trials
